CIBC Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CIBC Asset Management's BLUE Position: Q3 2019 in Review
CIBC Asset Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 137 shares — an estimated $226K sold.
CIBC Asset Management first reported a position in BLUE in Q4 2017 and held it in 6 quarters. The position peaked at $280K in Q1 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.
- CIBC Asset Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
- CIBC Asset Management sold 137 bluebird bio shares in Q3 2019, an estimated $226K.
- CIBC Asset Management first reported a position in bluebird bio in Q4 2017 and held it in 6 quarters.
- CIBC Asset Management's bluebird bio position peaked at $280K in Q1 2019.
- 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.
Based on CIBC Asset Management's 13F filing for Q3 2019, filed 30 Oct 2019.